APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,810,482 | +465.3% | 129,700 | +309.1% | 3.60% | +516.6% |
| Q1 2023 | $2,089,347 | +27.5% | 31,700 | 0.0% | 0.58% | +15.2% |
| Q4 2022 | $1,638,256 | -95.0% | 31,700 | +2056.5% | 0.51% | +49.3% |
| Q2 2022 | $32,500,000 | +2015.9% | 1,470 | -95.5% | 0.34% | -2.0% |
| Q1 2022 | $1,536,000 | 0.0% | 32,500 | 0.0% | 0.35% | +1.2% |
| Q4 2021 | $1,536,000 | +4.1% | 32,500 | +38.9% | 0.34% | -12.3% |
| Q2 2021 | $1,476,000 | +47.5% | 23,400 | 0.0% | 0.39% | +47.2% |
| Q1 2021 | $1,001,000 | – | 23,400 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |